Advertisement
Research Article

Differential Expression of Novel Potential Regulators in Hematopoietic Stem Cells

  • E. Camilla Forsberg equal contributor mail,

    equal contributor Contributed equally to this work with: E. Camilla Forsberg, Susan S Prohaska

    To whom correspondence should be addressed. E-mail: cforsber@stanford.edu

    Affiliation: Departments of Pathology and Developmental Biology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University Medical School, Stanford, California, United States of America

    X
  • Susan S Prohaska equal contributor,

    equal contributor Contributed equally to this work with: E. Camilla Forsberg, Susan S Prohaska

    Affiliation: Departments of Pathology and Developmental Biology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University Medical School, Stanford, California, United States of America

    X
  • Sol Katzman,

    Affiliation: Biomolecular Engineering, University of California at Santa Cruz, Santa Cruz, California, United States of America

    X
  • Garrett C Heffner,

    Affiliation: Departments of Pathology and Developmental Biology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University Medical School, Stanford, California, United States of America

    X
  • Josh M Stuart,

    Affiliation: Biomolecular Engineering, University of California at Santa Cruz, Santa Cruz, California, United States of America

    X
  • Irving L Weissman

    Affiliation: Departments of Pathology and Developmental Biology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University Medical School, Stanford, California, United States of America

    X
  • Published: September 02, 2005
  • DOI: 10.1371/journal.pgen.0010028

About the Authors

E. Camilla Forsberg, Susan S Prohaska, Garrett C Heffner, Irving L Weissman
Departments of Pathology and Developmental Biology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University Medical School, Stanford, California, United States of America
Sol Katzman, Josh M Stuart
Biomolecular Engineering, University of California at Santa Cruz, Santa Cruz, California, United States of America

Corresponding Author

Email: cforsber@stanford.edu

Competing Interests

As a former advisory board member of Amgen, ILW owns significant Amgen stock. He also cofounded and consulted for Systemix; cofounded Cellerant Therapeutics, a spin-off from Systemix Novartis to transplant human HSC; and is a cofounder and a director of the company Stem Cells, which is involved in the isolation and study of human central nervous system stem cells, liver-repopulating cells, and pancreatic islet/progenitor cells.

Author Contributions

ECF, SSP, and ILW conceived and designed the experiments. ECF, SSP and GCH performed the experiments. All authors analyzed the data. SK and JMS contributed reagents/materials/analysis tools. ECF wrote the paper.